Drug Facts Panel for Sunscreens: Getting Bemotrizinol Labeling Right
- Alok Naik, MS- Regulatory Affairs

- 4 days ago
- 2 min read
Updated: 13 hours ago
When an international sunscreen fails to make it onto a U.S. shelf, the label is usually why. In the United States, sunscreens are OTC drugs, and that means a Drug Facts panel — a strict, standardized format that looks nothing like a cosmetic label. Here's what it requires and where bemotrizinol products go wrong.
What the Drug Facts panel must contain
The panel follows a fixed order and wording. At a minimum it covers:
Active ingredient(s) — including bemotrizinol and its concentration (up to 6%), with purpose.
Purpose — e.g., sunscreen.
Uses — the permitted use statements for sunscreens.
Warnings — including the required skin-cancer/skin-aging and other monograph warnings.
Directions — application and reapplication instructions.
Other information and inactive ingredients.
Claims you can and can't make
Your SPF value, broad-spectrum designation, and any water-resistance claim must each be supported by testing on the final formulation under the monograph's methods. Claims that outrun the data — or use language the monograph doesn't permit — are a fast route to a misbranding problem.
Where bemotrizinol labels go wrong
The recurring errors are predictable: a home-market layout never converted to Drug Facts; an active-ingredient declaration that doesn't match the formulation; SPF or broad-spectrum claims without matching test reports; and missing or reworded mandatory warnings. Each is fixable before launch — and far cheaper to fix before than after.
Get it reviewed before you print
A label review against the Drug Facts format and your supporting tests is one of the highest-leverage things you can do pre-launch. It's also the step brands most often skip.
Get the checklist
Labeling is one section of our Bemotrizinol (BEMT) U.S. Market-Entry Compliance Checklist. Download the free checklist → Or have Axentra review your label directly as part of the U.S. Market Entry Package.
Frequently asked questions
Can I keep my existing international sunscreen label for the U.S.?
Almost never as-is. U.S. sunscreens require a Drug Facts panel in a specific format, so most international labels need to be rebuilt.
Does my SPF claim need U.S. testing?
Your SPF, broad-spectrum, and water-resistance claims must be supported by testing on the final formulation under the monograph's methods.
What happens if my label isn't compliant?
A non-compliant label can render the product misbranded, which can lead to detention, refusal, or enforcement action.
Comments